Journey Medical Corp (DERM) Interest Expense USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Journey Medical Corp quarterly/annual Interest Expense history and growth rate from 2021 to 2024.
  • Journey Medical Corp Interest Expense for the quarter ending March 31, 2024 was $548 K, a 15.7% decline year-over-year.
  • Journey Medical Corp Interest Expense for the twelve months ending March 31, 2024 was $1.6 M, a 30% decline year-over-year.
  • Journey Medical Corp annual Interest Expense for 2023 was $1.7 M, a 15.9% decline from 2022.
  • Journey Medical Corp annual Interest Expense for 2022 was $2.02 M, a 71.3% decline from 2021.
  • Journey Medical Corp annual Interest Expense for 2021 was $7.03 M, a 908% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.6 M $548 K -$102 K -15.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.7 M $24 K -$593 K -96.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.29 M $268 K -$291 K -52.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.58 M $756 K +$302 K +66.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.28 M $650 K +$261 K +67.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.02 M $617 K -$3.48 M -84.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $5.5 M $559 K -$814 K -59.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $6.31 M $454 K -$888 K -66.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $7.2 M $389 K +$168 K +76% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $7.03 M $4.1 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.37 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.34 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $221 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.